Showing 4831-4840 of 5646 results for "".
- Trump Health Official Says COVID Patients Should Not Re-Test. ‘It’s clogging up the system.’https://modernod.com/news/trump-health-official-says-covid-patients-should-not-re-test-its-clogging-up-the-system/2478038/The Trump administration plans to release guidance that non-hospitalized patients who test positive for COVID-19 do not need a second test to confirm they are clear of the virus, according to a FierceHealthcare
- National Vision Announces Special Cash Bonus to Front-Line Associates and Doctorshttps://modernod.com/news/national-vision-announces-special-cash-bonus-to-front-line-associates-and-doctors/2478032/National Vision Holdings announced plans to grant a special cash bonus to front-line associates and doctors. A one-time $250 bonus will be given to all patient-facing and customer-facing associates and the company’s network of doctors in recognition of their hard work and dedication toward
- Topcon Acquires Henson Perimeter Businesshttps://modernod.com/news/topcon-acquires-henson-perimeter-business/2478033/Topcon Healthcare announced that it has acquired the Henson line of perimetry products, including the Henson 9000 and 7000, from Elektron Eye Technology (EET) of Cambridge, UK. Terms of the deal were not disclosed. The acquisitions include the transfer of a number of EET staff to To
- Ocular Therapeutix Announces Its First Published Physician Fee Schedule for Administration of Intracanalicular Insertshttps://modernod.com/news/ocular-therapeutix-announces-its-first-published-physician-fee-schedule-for-administration-of-intracanalicular-inserts/2478025/Ocular Therapeutix announced that Novitas Solutions, one of seven Medicare Administrative Contractors (MACs), became the first MAC to establish a physician fee schedule for procedure code 0356T for the administration of drug-elutin
- Nicox Reports on Enrollment Progress in Mont Blanc Phase 3 Clinical Trial in Glaucomahttps://modernod.com/news/nicox-reports-on-enrollment-progress-in-mont-blanc-phase-3-clinical-trial-in-glaucoma/2478024/Nicox SA announced that over 40 sites have been initiated in the first month of the phase 3 Mont Blanc trial, evaluating NCX 470 for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension. NCX 470 is the company’s novel, second-generation nitric oxide (NO)-donating bimato
- AstraZeneca, IQVIA Partner to Speed Up Studies of COVID-19 Vaccine Candidatehttps://modernod.com/news/astrazeneca-iqvia-partner-to-speed-up-studies-of-covid-19-vaccine-candidate/2478022/AstraZeneca and IQVIA are teaming up to accelerate development of the UK drugmaker’s Oxford University-partnered COVID-19 vaccine candidate AZD1222, IQVIA announced Tuesday. According to the life sciences data analytics firm, the collaboration will “drive faster delivery of clin
- National Glaucoma Research Foundation Survey Reveals Patients’ Experiences and Concerns During COVID-19https://modernod.com/news/national-glaucoma-research-foundation-survey-reveals-patients-experiences-and-concerns-during-covid-19/2478017/Glaucoma Research Foundation (GRF) announced results from a survey designed to explore glaucoma patients’ experiences and concerns during the COVID-19 pandemic-related shutdowns. The survey, conducted among patients in the GRF database and suppo
- SimulEYE BIO Shield Launchedhttps://modernod.com/news/simuleye-bio-shield-launched/2478014/SimulEYE Ophthalmic Surgical Training Models has launched the SimulEYE BIO Shield, which is designed to protect eye care professionals and patients. The lightweight shield easily and securely mounts to a wall, using a proprietary magnet system, according to SimulEYE. The shield can be snap
- Searchable Contact Lens Database Launched in U.S.https://modernod.com/news/searchable-contact-lens-database-launched-in-u-s/2478010/For the first time, the searchable contact lens database for eye care practitioners—the Contact Lens Compendium—is accessible in the United States. With the launch of the U.S. version (https://compendium.contactlensupdate.com/us), ECPs now
- CorNeat Vision’s Synthetic Cornea Approved for First-in-Human Implantationhttps://modernod.com/news/corneat-visions-synthetic-cornea-approved-for-first-in-human-implantation/2478011/The CorNeat KPro, which says it is developing the first synthetic cornea that bio-integrates with the eye wall, received approval to begin a clinical trial at Beilinson Hospital, Israel. The clinical trial, approved by Israel’s